Levobupivacaine Fresenius Kabi Deutschland

Levobupivacaine, the active ingredient in Levobupivacaine Fresenius Kabi Deutschland, is an amide‑type local anesthetic presented as a sterile solution for epidural use. It is indicated for epidural anesthesia during surgical procedures, postoperative pain control, and labor analgesia, offering a long‑lasting sensory block with reduced motor impairment. Administration is performed by an anesthesiologist under controlled conditions.

GNH USA supplies Levobupivacaine Fresenius Kabi Deutschland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levobupivacaine is used in the field of regional anesthesia and peri‑operative pain management.

- Epidural anesthesia: provides surgical anesthesia for procedures requiring a dense sensory block. - Postoperative analgesia: reduces pain intensity after major surgery, facilitating early mobilization. - Labor analgesia: offers effective pain relief during childbirth while preserving maternal motor function.

Levobupivacaine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypotension: transient drop in blood pressure after epidural administration. - Bradycardia: slowed heart rate, particularly in patients with high spinal block. - Nausea: mild gastrointestinal upset following the procedure. - Injection site pain: discomfort at the epidural insertion site.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Seizures: central nervous system toxicity at high plasma concentrations. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery. - Allergic reactions: anaphylaxis or severe hypersensitivity requiring immediate intervention.

When using Levobupivacaine, clinicians should observe several safety measures.

- Cardiac monitoring: patients with pre‑existing heart disease require continuous ECG observation. - Dose adjustment: reduce total dose in elderly or frail patients to avoid toxicity. - Hepatic impairment: use caution in patients with liver dysfunction as metabolism may be slowed. - Hypersensitivity: avoid in individuals with known allergy to amide‑type local anesthetics. - Storage: Store at ambient temperature: keep in the original container, protect from light and moisture.

Levobupivacaine can interact with other drugs, influencing its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine): may potentiate cardiotoxic effects. - Beta‑blockers: increase risk of severe bradycardia and hypotension. - Calcium channel blockers: can exacerbate cardiac conduction delays.

Moderate Interactions (Monitor Closely): - Opioids: additive central nervous system depression may occur. - Benzodiazepines: enhanced sedation and respiratory depression risk. - Epinephrine (as an additive): may increase systemic absorption and toxicity.